Zhejiang Hisun Pharmaceutical Co., Ltd.SSE: 600267

Announcement on the Subsidiary Obtaining New Veterinary Drug Registration Certificate

· Issued by Zhejiang Hisun Pharmaceutical Co., Ltd. via Shanghai Stock Exchange

Filed with SSE · · 2 pages · Chinese

Summary by 6ix AI

Zhejiang Hisun Pharmaceutical Co., Ltd. announced that its subsidiary has obtained a new veterinary drug registration certificate for a product used in treating canine inflammatory and allergic diseases.

Written in English by 6ix AI from the company’s Chinese-language filing. How 6ix writes summaries

Release

Announcement on the Subsidiary Obtaining New Veterinary Drug Registration Certificate

The abstract is for reference only. Please refer to the full text of the announcement on the very day.

Link of Full Text for Reference:

Zhejiang Hisun Pharmaceutical Co., Ltd. on 6ix

Earlier from Zhejiang Hisun Pharmaceutical

Later from Zhejiang Hisun Pharmaceutical

All Zhejiang Hisun Pharmaceutical news releases